Home > Boards > US Listed > Biotechs >

Blueprint Medicines Corporation (BPMC)

Add BPMC Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 9/13/2017 1:59:50 PM - Followers: 6 - Board type: Free - Posts Today: 0

Blueprint Medicines is a patient-driven oncology company developing highly selective kinase inhibitors for genomically defined cancer subsets. Led by a management team and advisors with world-renowned expertise in cancer genomics, drug discovery and clinical oncology, Blueprint has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling Blueprint to rapidly develop potent highly selective compounds against clear genomic driver targets.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BPMC News: Current Report Filing (8-k) 01/08/2018 09:04:29 AM
BPMC News: Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common ... 12/15/2017 04:01:00 PM
BPMC News: Current Report Filing (8-k) 12/13/2017 04:54:33 PM
BPMC News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 12/13/2017 04:52:24 PM
BPMC News: Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock 12/12/2017 10:49:00 PM